Janet Vaughn is Vice President North America Generics Regulatory Affairs at Teva Pharmaceuticals USA. Prior to joining Teva, Janet held positions in analytical research, quality assurance and regulatory affairs at various companies. She joined Teva in January 2000 and in her current role, she provides regulatory guidance, manages and leads teams in strategic decision-making, ensuring quality submissions to the Food and Drug Administration. She is intimately involved with aspects of generic drug development that have resulted in securing FDA approvals for various products. Janet has a combined regulatory experience of more than 30 years.